Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

2.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.6K
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

484
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
484
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

6.2K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
6.2K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.4K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.2K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.2K
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists01:27

Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists

425
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
425

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Baseline risk markers and visit-to-visit variability in relation to kidney outcomes - A post-hoc analysis of the PERL study.

Diabetes research and clinical practice·2022
Same author

Vitamin D Supplementation for the Treatment of Depressive Symptoms in Women with Type 2 Diabetes: A Randomized Clinical Trial.

Journal of diabetes research·2022
Same author

The effects of cannabis and cannabinoids on the endocrine system.

Reviews in endocrine & metabolic disorders·2021
Same author

SARS-CoV-2 (COVID-19) and the Endocrine System.

Journal of the Endocrine Society·2020
Same author

Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring.

Journal of diabetes and its complications·2020
Same author

Vitamin D Supplementation and Cognition in People with Type 2 Diabetes: A Randomized Control Trial.

Journal of diabetes research·2019

Related Experiment Video

Updated: Nov 11, 2025

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.1K

Desensitization to Methimazole.

Alaleh Mazhari1, Mary Ann Emanuele1, Baltazar Espiritu1

  • 1Loyola University Medical Center, Maywood, Illinois.

Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|March 29, 2021
PubMed
Summary

Methimazole desensitization allows continued treatment for hyperthyroidism patients with side effects like rash or itching. This allergy management option enables continued methimazole use, avoiding propylthiouracil.

Keywords:
MMIPTUallergic reactiondesensitizationmethimazolepropylthiouracil

More Related Videos

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

8.9K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.1K

Related Experiment Videos

Last Updated: Nov 11, 2025

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

2.1K
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
06:31

Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response

Published on: October 3, 2019

8.9K
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.1K

Area of Science:

  • Endocrinology
  • Allergy and Immunology
  • Pharmacology

Background:

  • Thionamides, including methimazole and propylthiouracil, are standard treatments for hyperthyroidism.
  • Common side effects include rash and pruritus, while rare but serious effects include agranulocytosis and hepatotoxicity.
  • Methimazole is often preferred due to less frequent dosing and lower hepatotoxicity risk, but side effects can necessitate alternative strategies.

Purpose of the Study:

  • To evaluate the efficacy and safety of methimazole desensitization in patients experiencing side effects.
  • To explore methimazole desensitization as an alternative management option for hyperthyroidism when standard treatment is limited by adverse reactions.

Main Methods:

  • A retrospective chart review was conducted at a single institution.
  • Seven patients with methimazole-induced side effects (excluding agranulocytosis and hepatotoxicity) underwent desensitization under allergist supervision.

Main Results:

  • All seven patients successfully tolerated methimazole after desensitization.
  • Methimazole therapy was continued for hyperthyroidism management, serving as ongoing treatment or a bridge to definitive therapies like surgery or radioactive iodine.

Conclusions:

  • Methimazole desensitization, supervised by an allergist, is a viable option for patients with non-severe side effects.
  • This approach allows continued methimazole treatment, offering an alternative to switching to propylthiouracil or discontinuing therapy.